|
| Human SLAMF7/CRACC/CD319 Protein (LTP10912) |
|
| LTP10912 |
|
| 100ug |
|
|
$473 In stock |
| CD2-like receptor activating cytotoxic cells (CRACC), also known as CS1, novel Ly9, SLAMF7, and CD319, is a 65-75 kDa type I transmembrane glycoprotein in the SLAM subgroup of the CD2 family.Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. |
| Recombinant Human SLAMF7/CRACC/CD319 Protein is expressed from Expi293 with mFc (IgG1) tag at the C-terminal. It contains Ser23-Met226 |
|
| SLAMF7/CRACC/CD319 |
|
| Human |
|
| Q9NQ25-1 |
|
| Ser23-Met226 |
|
| The protein has a predicted MW of 48.8 kDa. Due to glycosylation, the protein migrates to 68-72 kDa based on the Tris-Bis PAGE result. |
|
| Immobilized Human SLAMF7, mFc Tag at 0.2ug/ml (100ul/Well). Dose response curve for Anti-SLAMF7 Ab., hFc Tag with the EC50 of 13.52ng/ml determined by ELISA. See testing image for detail. |
|
| C-mFc |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
